デフォルト表紙
年間契約型情報サービス
商品コード
1158127

バイオベース材料の中国市場:ニュースレター(四半期ベース)

Bio-based Material Quarterly Newsletter

出版日: 年12回 年間契約型情報サービス | 発行: CCM Data & Business Intelligence | ページ情報: 英文 27 Pages

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオベース材料の中国市場:ニュースレター(四半期ベース)
出版日: 年12回 年間契約型情報サービス
発行: CCM Data & Business Intelligence
ページ情報: 英文 27 Pages
  • 全表示
  • 概要
  • 目次
概要

当ニュースレターでは、中国のバイオベース材料市場について調査分析し、原材料から最終消費まで、産業チェーン全体におけるリアルタイムの最新情報を提供しています。中国と海外の最新ニュース、最新の市場データ(価格、輸出入、生産、消費、稼働率など)、市場動向の詳細な分析、業界関係者による専門家の解説などが含まれています。

目次

ヘッドライン

編集後記

政府指示

  • 中国が高品質の原材料産業の発展のための実施計画を発表

市場分析

  • Jindan TechnologyとKingfaが上半期の決算を発表
  • Zhongke Biotech & Cathay Biotech:LCDA・PAプロジェクトの発展
  • Hisun Biomaterialsが上海のSTAR市場にデビュー
  • COFCO Biotechが生分解性材料プロジェクトを進展

企業力学

  • 中国のPLAプロジェクトの進歩
  • 中国における新バイオベースの繊維/繊維複合材プロジェクト
  • BBCA Biochemicalが5,000t/aのD-乳酸、3,000t/aのPLA工業化プロジェクトを立案
  • Zhangjiagang JiutaiがPTTの新バイオベース材料を生産
  • Jinzhu New MaterialとAnhui Huizhuにおけるバイオベースプロジェクトの宣伝

価格の最新動向

ニュース概要

  • Angel YeastとWeigou Workshopが中国最大の30,000t/aのPHA生産拠点を共同設立
  • Huakang PharmaがLA・PLAを含む200万t/aのトウモロコシ加工プロジェクトを計画
  • CellUranicsが数千万人民元のエンジェル融資を終了
  • GS Biotechによるバイオベースの分解性材料ベースプロジェクトが建設を開始
  • Huaheng BiotechがSA・PDO工業化を推進
  • Puyang Baiaomaisiが50t/aのFDCAパイロットスケール設備の操業を開始
  • Zhongshanの共重合体がデンプンベースの生分解性材料プロジェクトで承認される
目次

In Sept., China's MIIT and the other departments jointly issued an implementation plan for the high-quality development of the raw

materials industry, with the development of bio-based materials listed as one of the primary tasks.

Jindan Technology reported operating revenue and net profit for H1 with huge year-on-year increases and moving forward with a new

PLA project, the designed capacity of which has been scaled up from 10,000 t/a to 75,000 t/a; while Kingfa's net profit tumbled, deferring its plan for putting the 30,000 t/a PLA project into operation.

Zhongke Biotech and Cathay Biotech both delivered remarkable financial performance for H1 2022. The two companies have

been actively setting up production capacities of long-chain dibasic acids (LCDAs) and bio-based polyamides (PAs).

On 16 Aug., Hisun Biomaterials made IPO on the Shanghai's STAR Market, boasting fast-growing revenue and sustainable capacity

improvement of PLA over the past three years.

COFCO Biotech reported a 12.21% year-on-year increase in its net profit for H1 2022, with ongoing initiatives to propel biodegradable

materials PHA, PLA, and lactide projects.

In this Q3, China sees new developments in PLA industry, including projects in Jiangxi Keyuan and Langjing New Material, and the

proposal for 300,000 t/a PLA construction raised by Zhongke Baichuang Environmental Biotechnology (Guantao) Co., Ltd.

In Aug.-Sept., two new bio-based fibre projects were publicised and one bio-based fibre composite project was resubmitted for approval to proceed.

On 6 Sept., BBCA Biochemical published an EIA report (exposure draft) of its 5,000 t/a D-lactic acid industrialisation demonstration

project and the 3,000 t/a PLA industrialisation demonstration project.

On 31 Aug., the EI report of Zhangjiagang Jiutai's 30,000 t/a PTT new bio-based material project was approved.

In Aug., the EI reports for the bio-based new material (bamboo-based cellulose) constructions of Jinzhu New Material and Anhui Huizhu

were posted for public review, the 1st phase of each accounts for capacity of 100,000 t/a.

Bio-based Material Quarterly Newsletter provides you with real-time intelligence on China's biomaterial market.

This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire bio-based materials industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.

Table of Contents

Headline

Editor's Note

Governmental Direction

China releases implementation plan for high-quality raw material industry development

Market Analysis

Jindan Technology and Kingfa release performance reports for H1

Zhongke Biotech & Cathay Biotech: Developments in LCDA and PA projects

Hisun Biomaterials makes debut on Shanghai's STAR Market

COFCO Biotech progresses biodegradable materials projects

Company Dynamics

Advance of China's PLA projects

New bio-based fibre / fibre composite projects in China

BBCA Biochemical drafts 5,000 t/a D-lactic acid and 3,000 t/a PLA industrialisation projects

Zhangjiagang Jiutai to produce PTT new bio-based material

Publicity of bio-based projects of Jinzhu New Material and Anhui Huizhu

Price Update

News in Brief

Angel Yeast and Weigou Workshop to co-found China's biggest 30,000 t/a PHA production base

Huakang Pharma planning 2 million t/a corn processing project including LA and PLA

CellUranics closes tens of millions RMB of angel financing

GS Biotech's bio-based degradable materials base project kicks start construction

Huaheng Biotech pushes SA and PDO industrialisation

Puyang Baiaomaisi initiates operation of 50 t/a FDCA pilot-scale equipment

Zhongshan Co-polymer approved for starch-based biodegradable material project